ArticleJournal of anesthesia, analgesia and critical care2026
Dual-opioid spinal anaesthesia in enhanced recovery after caesarean section: effects on postoperative opioid requirement and maternal recovery.
Article in Journal of anesthesia, analgesia and critical care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOptimisation of post-caesarean delivery and perioperative outcomes have emerged as a pivotal concern in obstetrics. The primary aim of this study was to evaluate the effects of implementing Enhanced Recovery After Caesarean Section (ERAC) combined with a pre-existing dual-opioid subarachnoid anaesthesia technique on the decrease in rescue opioid doses needed for acute pain management after caesarean delivery. The secondary aim was to compare the postoperative outcomes before and after the implementation of the ERAC pathway.
methodsWe conducted an observational, retrospective single-centre study involving 322 pregnant women, 156 pre-ERAC, and 166 post-ERAC. The eligible women were > 18 years old, without invasive placental disorders, no prior abdominal surgery with longitudinal laparotomy, and no disease. All women received subarachnoid anaesthesia with sufentanil and morphine, in addition to local anaesthetic and postoperative analgesia with paracetamol and ketorolac. Acute pain assessment was performed with a numeric pain rating scale (NRS); if the NRS was ≥ 4, a rescue dose of tramadol was administered in both groups.
resultsSignificant reductions in the need for rescue opioid analgesia were observed in the ERAC group, with logistic regression confirming an 84.5% reduction on postoperative day one. Additionally, outcomes, including early mobilisation, spontaneous diuresis, and return of gastrointestinal function, improved. The ERAC group also demonstrated a higher rate of discharge on the second postoperative day.
conclusionsThe findings of our study suggest that implementing the ERAC strategy with a pre-existing dual-opioid subarachnoid anaesthesia technique may be associated with reduced opioid requirements following caesarean delivery and to improved maternal outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.